Blood thinners and COVID: The findings guiding patient care

When SARS-CoV-2, the virus that causes COVID-19, first emerged in late 2019, researchers quickly assembled to understand its effects and figure out how to stop its spread. Soon, late-night phone calls and global collaborations morphed into international alliances, including the NIH-supported Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV), a public-private partnership that started in April 2020.